Compare GSK plc (GSK) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Energy Select Sector SPDR Fund — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while Energy Select Sector SPDR Fund trades at $65.09 (market cap $40.84B). The key difference: GSK plc is far larger — about 2.2× Energy Select Sector SPDR Fund's market cap, and GSK plc pays a 3.9% dividend while Energy Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| GSK | XLE | |
|---|---|---|
Market Cap | $91.88B | $40.84B |
Volume | 7,730,529 | 50,409,268 |
Sector | Health | — |
52-Week High | $61.18 | $65.93 |
52-Week Low | $43.24 | $42.61 |
Typical Hold Time | 93 Days | 67 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.36 exceeding the $1.27 estimate. Fundamentals show robust profitability with a 72.73% gross margin and 14.52% net margin, while valuation metrics like a P/E of 14.89 appear reasonable. Recent news highlights pipeline advancements, including a $750 million cancer therapy deal and strategic focus on oncology and cost savings.
The outlook is mixed; analyst consensus leans Hold (55.18%) with a minority Buy rating (31.03%), reflecting caution amid an approaching HIV patent cliff. Near-term support is at $45, with resistance at $47. Revenue growth to $33.2B in 2026 and a dividend of $0.45 per share offer stability, but execution risks and competitive pressures remain key watchpoints for investors.
XLE trades at $65.24, up 2.93% with strong bullish momentum from moving averages but overbought RSI signals. The energy ETF benefits from oil price surges above $100 and Middle East tensions, though futures traders bet on a 12% sector decline. Dividend yield remains modest with a $0.38 distribution scheduled for September 2026.
Outlook hinges on oil price sustainability amid geopolitical risks and Fed policy. Key risks include oil volatility and strategic reserve releases. Analysts show mixed signals with technical strength but fundamental data gaps warrant caution for energy sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
